Loading...
Loading...
AYTU| Name | Value |
|---|---|
| Revenues | 22.9M |
| Cost of Revenue | 6.7M |
| Gross Profit | 16.2M |
| Operating Expense | 12.5M |
| Operating I/L | 2.4M |
| Other Income/Expense | -1.8M |
| Interest Income | 0.0M |
| Pretax | 0.6M |
| Income Tax Expense | 0.8M |
| Net Income/Loss | -0.2M |
Aytu Biopharma, Inc. is a specialty pharmaceutical company that develops and commercializes novel therapeutics and consumer healthcare products. Their product portfolio includes Adzenys XR-ODT, Cotempla XR-ODT, and Adzenys ER for the treatment of ADHD, Karbinal ER for allergies, Poly-Vi-Flor and Tri-Vi-Flor supplements for fluoride deficiency, Tuzistra XR for cough, and ZolpiMist for insomnia. These products cater to a wide range of medical needs, generating revenue through the sale of prescription medications and healthcare supplements.
